Reading your medication list the way an underwriter does

An underwriter reading a prescription report is doing detective work in reverse. The report says which drugs were dispensed, when, in what strength and how often. It rarely says why. The underwriter infers a condition from the drug, tests that inference against your application answers, and asks questions where the two do not match. If you can read your own list the same way before you apply, you can see the questions coming and answer them with the full story instead of leaving a drug to speak for itself.

This walkthrough uses an invented list, labeled illustrative, for an invented applicant. Nothing here is a rule that every insurer follows, and none of it is medical advice. It is a way to read a list.

What a prescription report actually shows

Insurers commonly ask for permission on the application to look up your prescription fills in a commercial database. how insurers check your prescription history describes what those reports contain and how to get a copy. In short, a typical report lists the drug name and strength, the fill date, the quantity or days of supply, the prescriber and the pharmacy, usually covering several years.

Four fields do most of the work for an underwriter:

1. Drug and drug class. The name points to a family of medicines, and the family points to a short list of conditions.
2. Dose. The strength is a rough sign of how much treatment is needed.
3. Start date. The first fill dates the condition: recent diagnosis, long-standing, or something that changed lately.
4. Refill pattern. Regular fills on schedule suggest the drug is being taken as directed. Gaps suggest it was stopped, skipped or never started.

What the report does not include is the diagnosis, your test results, or your doctor's reasoning. That gap is why the same list can be harmless in one file and worrying in another, and why the application and any doctor's records matter.

The sample list

Say we are looking at a report for "Sam," a 46-year-old applying for a 20-year term policy. The list below is made up. The dates are written as months before the application, because only the pattern matters.

The next sections read each line the way an underwriter would. The goal is to show the logic, not to predict an outcome.

Line 1: lisinopril 10 mg, four years, steady

Lisinopril is in the ACE inhibitor family. The family is commonly used for high blood pressure and also for some heart and kidney conditions. An underwriter's first inference is high blood pressure, because it is the most common reason.

What the underwriter then asks: is blood pressure listed on the application? What are the recent readings? What is the dose, and has it changed? A low dose, stable for years, with normal readings at the paramedical exam, is the profile of well-controlled hypertension, which many insurers can accept at ordinary or near-ordinary pricing. See life insurance with high blood pressure for how control, age and readings are weighed.

What Sam should do: list the condition and the readings on the application if it asks about blood pressure treatment, and have recent home or office readings available. If the drug was prescribed for something other than blood pressure, such as protecting the kidneys in a person with another condition, say so, because that points to a different condition with its own questions.

Line 2: atorvastatin 20 mg, three years, steady

Atorvastatin is a statin. Statins are most often prescribed to lower cholesterol, and they are also given to some people mainly to reduce cardiovascular risk. The inference is high cholesterol, possibly with a cardiovascular risk factor.

The underwriter wants the cholesterol numbers before and on treatment. A moderate dose with good lab results is routine in underwriting. A higher dose, or the addition of a second cholesterol drug, suggests the first treatment was not enough. Combined with a blood pressure drug, a statin can also suggest a cluster of risk factors that the underwriter will weigh together. life insurance with high cholesterol explains the numbers that matter.

Line 3: sertraline 50 mg, 18 months, with gaps

Sertraline is an SSRI antidepressant. It is used for depression, anxiety disorders and several related conditions. The report cannot tell which. The underwriter will ask what condition it treats, how severe it was, whether it involved hospitalization or time off work, and whether it is now stable.

The gaps are what will draw attention. A month without the drug, twice, could mean Sam stopped when feeling better, forgot refills or switched pharmacies. An underwriter may ask whether the gaps reflect a change in the doctor's plan. A single honest sentence in the application or interview, such as "my doctor tapered it twice and restarted," carries more weight than a silent gap.

Mental health history is one of the areas where people most worry about disclosure. The factual position is that many applicants with treated depression or anxiety are approved, and severity, stability and the time since any serious episode matter more than the diagnosis name. life insurance with depression or anxiety covers the details. See also myths about therapy, privacy and life insurance applications.

Line 4: levothyroxine 75 mcg, seven years, every 90 days

Levothyroxine replaces thyroid hormone. The inference is an underactive thyroid. A 90-day supply on time, for seven years, at a stable dose is about as quiet as a prescription history gets. The underwriter may want to see a recent thyroid hormone test showing the dose is working, but a long-stable replacement of a single hormone is usually treated as a minor item.

The reading here is mostly about what is missing. No dose changes, no gaps and no added drugs form a picture of a controlled, uncomplicated condition. That is a useful thing to know, because it tells you where not to worry.

Lines 5 to 7: inhaler, acid reducer and migraine tablets

Albuterol inhaler, two fills in two years

Albuterol is a rescue inhaler used for asthma and other airway conditions. Two fills in two years suggests occasional use. The underwriter will ask about the diagnosis, how often symptoms occur, whether there have been emergency visits or steroid courses, and whether the person smokes. The fill count helps: an inhaler used twice in two years reads very differently from one filled every few weeks.

If an inhaler was prescribed for exercise or a seasonal reaction and the person has no continuing asthma, the application and a note from the doctor can say so. Life insurance with asthma or COPD explains the factors that usually decide the rating.

Omeprazole 20 mg, five years, irregular

Omeprazole reduces stomach acid and is used for reflux and related stomach conditions. It is also sold without a prescription, so the report may only show part of the use. The underwriter infers reflux. The question that sometimes follows is whether there are complications, such as a past procedure or an abnormal finding. Occasional use for ordinary heartburn is typically treated as minor. The irregular refills suggest it is taken as needed, which is consistent with that reading.

Sumatriptan, six tablets a fill

Sumatriptan is a migraine drug. Six tablets at a time, three fills in a year, suggest a person with migraines a few times a month or less. Migraines on their own are commonly underwritten leniently, though the underwriter may ask about neurological symptoms or other drugs used preventively. This is also a good illustration of why a drug name can mislead: if Sam were also on a drug that is used both for blood pressure and for migraine prevention, the report alone would not say which was intended.

Line 8: metformin 500 mg, four months, then stopped

This is the line an underwriter will linger on. Metformin is most associated with type 2 diabetes. It is also prescribed for prediabetes and for certain hormonal conditions. Started four months ago and filled only twice, it raises several questions at once:

• Was it a diagnosis of diabetes, prediabetes or something else?
• Why did it stop: a side effect, a switch to lifestyle change, a change in diagnosis, or a decision not to take it?
• What do the blood sugar tests (such as an A1C) show?

Say the true story is that Sam's doctor started metformin after a borderline blood sugar test, Sam lost weight over the next months and the doctor stopped it with a normal result. If Sam says nothing, the underwriter may reasonably assume diabetes. If Sam explains it on the application and the doctor's records support it, the file shows a borderline result that resolved. life insurance with type 1 or type 2 diabetes and the worksheet in a worksheet for organizing the diabetes records an underwriter will ask for show what documentation helps.

The lesson is general: the newest, shortest and most ambiguous line is the one worth explaining first. A second lesson is about timing. If the metformin was stopped only last month and the follow-up blood test has not been done, the cleanest answer may come from getting that test before applying, which is a question for your doctor, not the insurer. should you see your doctor before applying for life insurance? weighs that choice.

A third lesson is about dose. Had the line read metformin 1,000 mg twice a day with a second diabetes drug added, the inference would be a more established and harder-to-control condition, and the questions would shift from "what is this?" to "how well is it controlled?" Dose and the number of drugs in a class are how an underwriter reads severity without seeing a single lab value.

Reading the list as a whole

Underwriters do not read lines one at a time. They look for combinations:

• Blood pressure drug plus statin plus a diabetes drug suggests a cluster of cardiovascular risk factors.
• A sudden change in dose or the addition of a second drug in the same class suggests a condition that is harder to control.
• A drug that appears once and never again suggests a short course or a failed trial.
• A new class that does not match any application answer suggests a condition that was not disclosed or has just been diagnosed.

On Sam's list, the lines individually are ordinary. Together they show a person with treated blood pressure, treated cholesterol, a treated mood condition, a thyroid condition, mild asthma, reflux, migraines and one ambiguous recent drug. That is a lot of conditions for one application, though several are minor and well controlled. The likely underwriting questions are the metformin story, the sertraline gaps and the blood pressure readings, and an applicant who has thought about those three before the phone interview is far better placed than one who meets them cold. preparing for the life insurance underwriting phone interview covers how to prepare for that call.

Doing this exercise before you apply

1. Get your own list. Ask your pharmacy for a printout of your fills for the past several years, or request your prescription report; How to request your own MIB and prescription reports step by step walks through the steps.
2. Write the reason beside each drug. Use the doctor's words. For a drug with more than one use, write which one applies.
3. Add the start date and any dose changes. If a dose went up or down, note why.
4. Mark the gaps. For any month you skipped, write the reason.
5. Add what the report cannot show. Drugs bought without insurance, samples, and over-the-counter items do not show up, but the application may still ask about them.
6. Match each line to an application question. If a drug implies a condition the form asks about, the answer should say so.
7. Keep the worksheet. build a medical history worksheet before you apply for life insurance gives a fuller format for the whole health history.

When your list changes mid-application, and when it is wrong

A medication started, stopped or changed after you apply can change the file. A new prescription may appear in the database before the policy is issued, and the application often asks you to confirm at delivery that your health has not changed. If something changes, tell the agent promptly. a medication change while your application is pending: a checklist has a checklist for exactly this.

Reports can also be wrong. A prescription filled for a family member under a similar name, a fill that was never picked up, or a drug listed for the wrong date can all appear. Reporting companies provide a copy on request, and the Fair Credit Reporting Act gives you a way to dispute an entry. questions about disputing a wrong entry in your underwriting file covers the process. If the error is about why a drug was prescribed rather than a wrong entry, a short letter from your doctor often resolves it.

Key takeaways

• A prescription report shows drug, dose, start date and refill pattern; the underwriter infers the condition and then tests that inference against your application.
• The newest and most ambiguous prescriptions deserve explanation first, especially a short course of a drug that can mean several things.
• Gaps in refills are read as stopping, skipping or a change in plan; a one-sentence explanation usually beats silence.
• Annotating your own list with the reason, start date and any change turns the report from a puzzle into a record you control.
• Combinations of drugs matter more than any single drug, so look at the list as a whole before you answer the application.